Literature DB >> 31187992

Replacement of Protein Binding-Site Waters Contributes to Favorable Halogen Bond Interactions.

Yuanxun Wang1,2, Qiuyu Fu2,3, Yu Zhou2, Yunfei Du1, Niu Huang2,4.   

Abstract

Halogen bond interaction between a protein electronegative atom and a ligand halogen atom is increasingly attracting attention in the field of structure-based drug design. Nevertheless, gaps in understanding make it desirable to better examine the role of forces governing the formation of favorable halogen bond interactions, and the development of effective and efficient computational approaches to "design in" favorable halogen bond interactions in lead optimization process are warranted. Here, we analyzed the binding-site water properties of crystal structures with characterized halogen bond interactions between ligand halogen atoms and protein backbone carbonyl groups and, thus, found that halogen atoms involved in halogen bond interactions frequently replace calculated binding-site waters upon ligand binding. Moreover, we observed that the preferential directionality of halogen bond interactions aligns well with the orientations of these replaced waters, and these replaced waters exhibited differential energetic characteristics as compared to waters that are displaced by halogen atoms that do not form halogen bond interactions. Our discovery that replacement of calculated binding-site waters contributes to the formation of favorable halogen bond interactions suggests a practical approach for rational drug design utilizing halogen bond interactions with protein backbone carbonyl groups.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31187992     DOI: 10.1021/acs.jcim.9b00128

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  1 in total

1.  Identification of highly selective type II kinase inhibitors with chiral peptidomimetic tails.

Authors:  Seo-Jung Han; Jae Eun Jung; Do Hee Oh; Minsup Kim; Jae-Min Kim; Kyung-Sook Chung; Hee-Soo Han; Jeong-Hun Lee; Kyung-Tae Lee; Hee Jin Jeong; In Ho Park; Eunkyeong Jeon; Jeon-Soo Shin; Dongkeun Hwang; Art E Cho; Duck-Hyung Lee; Taebo Sim
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.